Background The incidence of early-onset colorectal cancer (EO-CRC; age 10%, whereas LO-CRC patients exhibited higher rates of hypertension, diabetes, and elevated carcinoembryonic antigen (CEA) levels. Although OS did not differ significantly between groups ( P = 0.460), their prognostic determinants varied markedly. In EO-CRC, distant metastasis, family history, Tumor, Node, and Metastasis (TNM) stage, PMS1 homolog 2, mismatch repair system component (PMS2), MutS Homolog 6 (MSH6), tumor size, concurrent polyps, and Ki-67 were major predictors. In LO-CRC, age, BRAF gene V600E mutation (BRAF V600E) mutation, elevated Carbohydrate antigen 19-9 (CA19-9), Ki-67, low hemoglobin, vascular invasion, MutL Homolog 1 (MLH1), and pathological type were significant contributors. The C-index values for the EO-CRC and LO-CRC models were 0.829 (SE = 0.023) and 0.751 (SE = 0.018), respectively, and all time-dependent ROC curves demonstrated Area Under the Curve (AUCs) above 0.70, indicating good predictive performance. RSF analyses further confirmed that distant metastasis and family history as the strongest predictors, while age and BRAF V600E are the strongest predictors for LO-CRC. Conclusion This study suggests that EO-CRC and LO-CRC have fundamentally different prognostic determinants: the former emphasizes genetic susceptibility and tumor invasiveness, indicating that this group of patients may benefit from early genetic counseling, MMR/MSI testing, and immune checkpoint inhibitor therapy. The latter highlights age, acquired molecular changes, and chronic systemic factors, supporting the inclusion of metabolic and geriatric assessments in routine tumor care.
Huang et al. (2026) studied this question.